With Silver's strength, it is very hard to understand how SSRI is trading so far below both its 50 week and 200 week moving averages with Silver nicely above both its 50 week and 200 week moving averages.

How can SSRI be in a downtrend versus the S&P 500 since mid May, 2009 when Silver has moved up roughly 20-30% since that time?

The following info is a little out of date....but still applicable:

July 31, 2009 Closing Prices:

SLV - $13.70

SSRI - $19.67

SLW - $9.18

PAAS - $19.71

HL - $3.15

July 30, 2010 Prices:

SLV - $17.45 (Up 27.4% since July 31, 2009)

SSRI - $16.18 (Down 17.7%)

SLW - $18.43 (Up 100.8%)

PAAS - $22.65 (Up 14.9%)

HL - $4.89 (Up 55.2%)

My question...what is the explanation for SSRI's dramatic underperformance over the past 12 months? Robert Quartermaine's departure?

Seems very undervalued for the amount of metal this company has in the pipeline. Almost 28 silver ounces per share silver reserves and resources, coupled with .6 gold ounces per share gold resources.

Is this stock a favorite of the institutions that are long the metal and short mining shares as a hedge? What gives?

I am a long time holder of SSRI...it has always been my favorite as I always loved the fact they were not mining their precious silver at low prices. I have a hard time understanding why these shares aren't trading much higher with Silver doing so well...